March 30, 2022 12:16 PM EDT
Pharma

EMA to clin­i­cal tri­al spon­sors: Use your Covid-re­lat­ed flex­i­bil­i­ties in re­spond­ing to Ukraine cri­sis

Zachary Brennan

Senior Editor

Eu­rope’s drug reg­u­la­tor told clin­i­cal tri­al spon­sors that are deal­ing with the fall­out from the war in Ukraine to use what they’ve learned from Covid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times